Annual FCF
-$78.56 M
+$19.66 M+20.01%
December 31, 2023
Summary
- As of February 26, 2025, FDMT annual free cash flow is -$78.56 million, with the most recent change of +$19.66 million (+20.01%) on December 31, 2023.
- During the last 3 years, FDMT annual FCF has fallen by -$26.65 million (-51.35%).
- FDMT annual FCF is now -1125.09% below its all-time high of $7.66 million, reached on December 31, 2017.
Performance
FDMT Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$31.17 M
-$577.00 K-1.89%
September 30, 2024
Summary
- As of February 26, 2025, FDMT quarterly free cash flow is -$31.17 million, with the most recent change of -$577.00 thousand (-1.89%) on September 30, 2024.
- Over the past year, FDMT quarterly FCF has dropped by -$29.59 million (-1877.73%).
- FDMT quarterly FCF is now -1877.73% below its all-time high of -$1.58 million, reached on September 30, 2023.
Performance
FDMT Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$116.76 M
-$29.59 M-33.95%
September 30, 2024
Summary
- As of February 26, 2025, FDMT TTM free cash flow is -$116.76 million, with the most recent change of -$29.59 million (-33.95%) on September 30, 2024.
- Over the past year, FDMT TTM FCF has dropped by -$40.09 million (-52.28%).
- FDMT TTM FCF is now -700.21% below its all-time high of -$14.59 million, reached on March 31, 2020.
Performance
FDMT TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
FDMT Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +20.0% | -1877.7% | -52.3% |
| 3 y3 years | -51.4% | -1877.7% | -52.3% |
| 5 y5 years | -371.4% | -1877.7% | -52.3% |
FDMT Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -0.4% | +20.0% | -1877.7% | at low | -52.3% | at low |
| 5 y | 5-year | -96.8% | +20.0% | -1877.7% | at low | -700.2% | at low |
| alltime | all time | -1125.1% | +20.0% | -1877.7% | at low | -700.2% | at low |
4D Molecular Therapeutics Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$31.17 M(+1.9%) | -$116.76 M(+34.0%) |
| Jun 2024 | - | -$30.59 M(+2.7%) | -$87.17 M(+9.7%) |
| Mar 2024 | - | -$29.80 M(+18.3%) | -$79.44 M(+1.1%) |
| Dec 2023 | -$78.56 M(-20.0%) | -$25.20 M(+1498.9%) | -$78.56 M(+2.5%) |
| Sep 2023 | - | -$1.58 M(-93.1%) | -$76.67 M(-21.8%) |
| Jun 2023 | - | -$22.87 M(-20.9%) | -$98.08 M(+0.9%) |
| Mar 2023 | - | -$28.92 M(+24.1%) | -$97.18 M(-1.1%) |
| Dec 2022 | -$98.22 M(+25.5%) | -$23.31 M(+1.4%) | -$98.22 M(-3.6%) |
| Sep 2022 | - | -$22.98 M(+4.6%) | -$101.85 M(+4.8%) |
| Jun 2022 | - | -$21.97 M(-26.7%) | -$97.22 M(+5.5%) |
| Mar 2022 | - | -$29.96 M(+11.3%) | -$92.19 M(+17.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$78.24 M(+50.7%) | -$26.93 M(+46.7%) | -$78.24 M(+12.9%) |
| Sep 2021 | - | -$18.36 M(+8.3%) | -$69.32 M(+8.3%) |
| Jun 2021 | - | -$16.94 M(+5.8%) | -$63.98 M(+20.0%) |
| Mar 2021 | - | -$16.01 M(-11.1%) | -$53.33 M(+2.7%) |
| Dec 2020 | -$51.91 M(+30.1%) | -$18.01 M(+38.3%) | -$51.91 M(+53.1%) |
| Sep 2020 | - | -$13.02 M(+107.1%) | -$33.90 M(+62.4%) |
| Jun 2020 | - | -$6.29 M(-56.9%) | -$20.88 M(+43.1%) |
| Mar 2020 | - | -$14.59 M | -$14.59 M |
| Dec 2019 | -$39.91 M(+139.5%) | - | - |
| Dec 2018 | -$16.67 M(-317.5%) | - | - |
| Dec 2017 | $7.66 M | - | - |
FAQ
- What is 4D Molecular Therapeutics annual free cash flow?
- What is the all time high annual FCF for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics annual FCF year-on-year change?
- What is 4D Molecular Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics quarterly FCF year-on-year change?
- What is 4D Molecular Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for 4D Molecular Therapeutics?
- What is 4D Molecular Therapeutics TTM FCF year-on-year change?
What is 4D Molecular Therapeutics annual free cash flow?
The current annual FCF of FDMT is -$78.56 M
What is the all time high annual FCF for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high annual free cash flow is $7.66 M
What is 4D Molecular Therapeutics annual FCF year-on-year change?
Over the past year, FDMT annual free cash flow has changed by +$19.66 M (+20.01%)
What is 4D Molecular Therapeutics quarterly free cash flow?
The current quarterly FCF of FDMT is -$31.17 M
What is the all time high quarterly FCF for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high quarterly free cash flow is -$1.58 M
What is 4D Molecular Therapeutics quarterly FCF year-on-year change?
Over the past year, FDMT quarterly free cash flow has changed by -$29.59 M (-1877.73%)
What is 4D Molecular Therapeutics TTM free cash flow?
The current TTM FCF of FDMT is -$116.76 M
What is the all time high TTM FCF for 4D Molecular Therapeutics?
4D Molecular Therapeutics all-time high TTM free cash flow is -$14.59 M
What is 4D Molecular Therapeutics TTM FCF year-on-year change?
Over the past year, FDMT TTM free cash flow has changed by -$40.09 M (-52.28%)